ANI PHARMACEUTICALS, INC — Revenue by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/214a119b-6025-436b-b082-799e20a901e1/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $883.4M | 2025-01-01 – 2025-12-31 | evidence 0001023024-26-000014 |
| FY 2024 | $614.4M | 2024-01-01 – 2024-12-31 | evidence 0001023024-25-000015 |
| FY 2023 | $486.8M | 2023-01-01 – 2023-12-31 | evidence 0001023024-24-000026 |
| FY 2022 | $316.4M | 2022-01-01 – 2022-12-31 | evidence 0001023024-23-000005 |
| FY 2021 | $216.1M | 2021-01-01 – 2021-12-31 | evidence 0001023024-22-000004 |
| FY 2020 | $208.5M | 2020-01-01 – 2020-12-31 | evidence 0001023024-21-000007 |
| FY 2019 | $206.5M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-025744 |
| FY 2018 | $201.6M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-010541 |
| FY 2017 | $176.8M | 2017-01-01 – 2017-12-31 | evidence 0001144204-19-010541 |
| FY 2016 | $128.6M | 2016-01-01 – 2016-12-31 | evidence 0001144204-19-010541 |
| FY 2015 | $76.3M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-083848 |
| FY 2014 | $56.0M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-011270 |
| FY 2013 | $30.1M | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-012277 |
| FY 2012 | $20.4M | 2012-01-01 – 2012-12-31 | evidence 0001144204-14-012277 |
| FY 2011 | $435.2k | 2011-01-01 – 2011-12-31 | evidence 0001104659-12-017928 |
| FY 2010 | $2.5M | 2010-01-01 – 2010-12-31 | evidence 0001104659-12-017928 |
| FY 2009 | $1.3M | 2009-01-01 – 2009-12-31 | evidence 0001104659-12-017928 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ANI PHARMACEUTICALS, INC — all facts · Net Income · Operating Income